Acceleron Pharma (XLRN) Stock Analyst Earnings Estimates
NASDAQ:XLRN - Nasdaq -
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.99M 3.78% | 73.99M 428.88% | 92.52M 25.04% | 139.562M 50.85% | 215.155M 54.16% | 302.159M 40.44% | 436.356M 44.41% | 642.756M 47.30% | |
| EBITDA YoY % growth | -120.66M -12.61% | -132.51M -9.82% | -163.46M -23.36% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -124.41M -13.12% | -136.45M -9.68% | -167.31M -22.62% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -889.28% | -184.42% | -180.84% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -2.59 0.77% | -2.38 8.11% | -2.90 -21.85% | -4.11 -41.56% | -3.39 17.52% | -2.12 37.48% | -2.65 -25.00% | -3.37 -27.50% |
| Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.91 4.57% | -1.02 3.18% | -0.95 9.33% | -0.84 27.72% | -0.71 21.92% | -1.01 0.67% | -0.85 11.07% | -0.87 -3.41% | -0.43 39.48% |
| Revenue Q2Q % growth | 45.41M 75.53% | 42.653M 72.27% | 49.215M 76.14% | 54.308M 58.80% | 62.88M 38.47% | 56.1M 31.53% | 69.564M 41.35% | 72.522M 33.54% | 107.61M 71.14% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -1.16 -75.76% | -1.01 | -0.15 | -15.29% |
| Q2 2021 Q2Q % growth | -1.05 -208.82% | -0.89 | -0.16 | -18.23% |
| Q1 2021 Q2Q % growth | -1.05 -10.53% | -0.83 | -0.22 | -26.32% |
| Q4 2020 Q2Q % growth | -0.95 -115.91% | -0.60 | -0.35 | -59.04% |
| Q3 2020 Q2Q % growth | -0.66 23.26% | -0.62 | -0.04 | -5.83% |
| Q2 2020 Q2Q % growth | -0.34 | -0.59 | 0.25 | 42.03% |
| Q1 2020 Q2Q % growth | -0.95 -28.38% | -0.88 | -0.07 | -7.93% |
| Q4 2019 Q2Q % growth | -0.44 | -0.30 | -0.14 | -46.94% |
| Q3 2019 Q2Q % growth | -0.86 | -0.83 | -0.03 | -3.12% |
| Q2 2019 Q2Q % growth | -0.34 | -0.30 | -0.04 | -12.38% |
| Q1 2019 Q2Q % growth | -0.74 | -0.60 | -0.14 | -23.21% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 34.199M 51.59% | 35.83M | -1.631M | -4.55% |
| Q2 2021 Q2Q % growth | 27.94M -29.71% | 31.413M | -3.473M | -11.06% |
| Q1 2021 Q2Q % growth | 24.76M 470.51% | 29.464M | -4.704M | -15.96% |
| Q4 2020 Q2Q % growth | 25.87M -34.24% | 32.953M | -7.083M | -21.49% |
| Q3 2020 Q2Q % growth | 22.56M 435.87% | 26.792M | -4.232M | -15.79% |
| Q2 2020 Q2Q % growth | 39.75M 43.66% | 30.683M | 9.067M | 29.55% |
| Q1 2020 Q2Q % growth | 4.34M 56.12% | 5.369M | -1.029M | -19.16% |
| Q4 2019 Q2Q % growth | 39.34M | 36.607M | 2.733M | 7.47% |
| Q3 2019 Q2Q % growth | 4.21M | 4.53M | -319.718K | -7.06% |
| Q2 2019 Q2Q % growth | 27.67M | 26.659M | 1.011M | 3.79% |
| Q1 2019 Q2Q % growth | 2.78M | 7.465M | -4.685M | -62.76% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |